These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17394936)

  • 61. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Animal-derived or synthetic surfactant for the treatment of neonatal respiratory distress syndrome: a review.
    Milligan DW; Ainsworth SB
    Acta Paediatr Suppl; 2001 Mar; 90(436):25-7. PubMed ID: 11332952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 64. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium.
    Bernhard W; Mottaghian J; Gebert A; Rau GA; von Der HARDT H; Poets CF
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1524-33. PubMed ID: 11029372
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome.
    Donn SM
    Expert Opin Investig Drugs; 2005 Mar; 14(3):329-34. PubMed ID: 15833063
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Continuous positive airway pressure and surfactant.
    Bohlin K; Jonsson B; Gustafsson AS; Blennow M
    Neonatology; 2008; 93(4):309-15. PubMed ID: 18525215
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aerosolized surfactants.
    Mazela J; Merritt TA; Finer NN
    Curr Opin Pediatr; 2007 Apr; 19(2):155-62. PubMed ID: 17496758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthetic protein analogues in artificial surfactants.
    Johansson J; Curstedt T; Robertson B
    Acta Paediatr; 1996 Jun; 85(6):642-6. PubMed ID: 8816196
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical experience with exogenous natural surfactant.
    Halliday HL
    Dev Pharmacol Ther; 1989; 13(2-4):173-81. PubMed ID: 2693000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New synthetic surfactant - how and when?
    Curstedt T; Johansson J
    Biol Neonate; 2006; 89(4):336-9. PubMed ID: 16770074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ultrastructure of exogenous surfactants using cryogenic scanning electron microscopy.
    Banerjee R; Bellare JR
    J Biomater Appl; 2001 Jan; 15(3):230-40. PubMed ID: 11261601
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcomes: what should the focus be?
    Aschner JL; Walsh MC
    Clin Perinatol; 2007 Mar; 34(1):205-17, ix. PubMed ID: 17394939
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 75. Expanded use of surfactant therapy in newborns.
    Lacaze-Masmonteil T
    Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes.
    Tridente A; De Martino L; De Luca D
    Respir Res; 2019 Feb; 20(1):28. PubMed ID: 30728009
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
    Donn SM; Dalton J
    Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surfactant protein profile of pulmonary surfactant in premature infants.
    Ballard PL; Merrill JD; Godinez RI; Godinez MH; Truog WE; Ballard RA
    Am J Respir Crit Care Med; 2003 Nov; 168(9):1123-8. PubMed ID: 12904326
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?
    Suresh GK; Soll RF
    Paediatr Drugs; 2002; 4(8):485-92. PubMed ID: 12126452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Superoxide dismutase and catalase activity in naturally derived commercial surfactants.
    Dani C; Buonocore G; Longini M; Felici C; Rodriguez A; Corsini I; Rubaltelli FF
    Pediatr Pulmonol; 2009 Nov; 44(11):1125-31. PubMed ID: 19830697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.